- Report
- November 2023
- 94 Pages
United States
From €5211EUR$5,950USD£4,523GBP
- Report
- April 2024
- 185 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- July 2024
- 120 Pages
Global
From €4160EUR$4,750USD£3,611GBP
- Report
- October 2023
- 146 Pages
Global
From €3635EUR$4,150USD£3,155GBP
- Report
- May 2023
- 95 Pages
Global
From €3500EUR$4,281USD£3,144GBP
Iodinated Contrast Media (ICM) is a type of contrast media used in medical imaging to enhance the visibility of organs, tissues, and vessels. It is typically administered intravenously, and is composed of iodine-based compounds that absorb X-rays and create a contrast between the area of interest and the surrounding tissue. ICM is used in a variety of medical imaging procedures, including computed tomography (CT), magnetic resonance imaging (MRI), and angiography.
ICM is a critical component of medical imaging, as it allows for the accurate diagnosis of a variety of medical conditions. It is also used to monitor the progress of treatments, such as chemotherapy and radiation therapy.
The ICM market is highly competitive, with a number of companies offering a range of products. Some of the major players in the market include Bayer, Bracco Imaging, Guerbet, GE Healthcare, Lantheus Medical Imaging, Mallinckrodt, and Siemens Healthineers. Show Less Read more